[
  {
    "objectID": "publications/index.html",
    "href": "publications/index.html",
    "title": "Publications",
    "section": "",
    "text": "I have made contributions to neurosyphilis and cancer research, and my work has been published in journals including eClinicalMedicine, JMIR Public Health and Surveillance, among others. Besides, I have patented a clinical diagnosis system for neurological syphilis (LU504466, rank 1/1).\nIn addition to my work on neurosyphilis and cancer, I have extensive experience applying advanced statistical concepts, artificial intelligence, and causal inference methods to conduct real-world research based on electronic health records. I have conducted multiple studies in the areas of COVID-19, HPV and HIV infections, and cardiovascular disease."
  },
  {
    "objectID": "publications/index.html#journal-articles",
    "href": "publications/index.html#journal-articles",
    "title": "Publications",
    "section": "Journal articles",
    "text": "Journal articles"
  },
  {
    "objectID": "publications/index.html#working-papers",
    "href": "publications/index.html#working-papers",
    "title": "Publications",
    "section": "Working papers",
    "text": "Working papers"
  },
  {
    "objectID": "publications/index.html#book-chapters",
    "href": "publications/index.html#book-chapters",
    "title": "Publications",
    "section": "Book chapters",
    "text": "Book chapters"
  },
  {
    "objectID": "publications/index.html#reviews",
    "href": "publications/index.html#reviews",
    "title": "Publications",
    "section": "Reviews",
    "text": "Reviews"
  },
  {
    "objectID": "publications/index.html#selected-seminar-papers",
    "href": "publications/index.html#selected-seminar-papers",
    "title": "Publications",
    "section": "Selected seminar papers",
    "text": "Selected seminar papers"
  },
  {
    "objectID": "publications/index.html#translations",
    "href": "publications/index.html#translations",
    "title": "Publications",
    "section": "Translations",
    "text": "Translations"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Hello there!",
    "section": "",
    "text": "I am a PhD candidate in epidemiology and biostatistics at Sun Yat-sen University. I have made contributions to neurosyphilis and cancer research, and my work has been published in journals including eClinicalMedicine, JMIR Public Health and Surveillance, among others. Besides, I have patented a clinical diagnosis system for neurological syphilis (LU504466, rank 1/1).\nIn addition to my work on neurosyphilis and cancer, I have extensive experience applying advanced statistical concepts, artificial intelligence, and causal inference methods to conduct real-world research based on electronic health records. I have conducted multiple studies in the areas of COVID-19, HPV and HIV infections, and cardiovascular disease.\nTo date (May 10, 2024), I have published 25 papers in peer-reviewed journals, serving as the first author and co-first author for 10 of these."
  },
  {
    "objectID": "blog/index.html#section",
    "href": "blog/index.html#section",
    "title": "Blog",
    "section": "2024",
    "text": "2024\n\n\n    \n    \n                  \n            May 13, 2024\n        \n        \n            Hierarchical composite endpoints治疗效应的可视化\n\n            \n            \n                \n                \n                    r\n                \n                \n                \n                    clinical trial\n                \n                \n                \n                    endpoint\n                \n                \n            \n            \n\n            复合终点治疗效应的可视化\n            \n            \n        \n        \n        \n            \n        \n        \n    \n    \n    \n                  \n            May 11, 2024\n        \n        \n            最优分类阈值\n\n            \n            \n                \n                \n                    python\n                \n                \n                \n                    machine learning\n                \n                \n            \n            \n\n            分类问题中阈值的选择\n            \n            \n        \n        \n        \n            \n        \n        \n    \n    \n\n\nNo matching items"
  },
  {
    "objectID": "blog/index.html#section-1",
    "href": "blog/index.html#section-1",
    "title": "Blog",
    "section": "2023",
    "text": "2023"
  },
  {
    "objectID": "blog/index.html#section-2",
    "href": "blog/index.html#section-2",
    "title": "Blog",
    "section": "2022",
    "text": "2022"
  },
  {
    "objectID": "blog/index.html#section-3",
    "href": "blog/index.html#section-3",
    "title": "Blog",
    "section": "2021",
    "text": "2021"
  },
  {
    "objectID": "blog/index.html#section-4",
    "href": "blog/index.html#section-4",
    "title": "Blog",
    "section": "2020",
    "text": "2020"
  },
  {
    "objectID": "blog/index.html#section-5",
    "href": "blog/index.html#section-5",
    "title": "Blog",
    "section": "2019",
    "text": "2019"
  },
  {
    "objectID": "blog/index.html#section-6",
    "href": "blog/index.html#section-6",
    "title": "Blog",
    "section": "2018",
    "text": "2018"
  },
  {
    "objectID": "blog/index.html#section-7",
    "href": "blog/index.html#section-7",
    "title": "Blog",
    "section": "2017",
    "text": "2017"
  },
  {
    "objectID": "blog/index.html#section-8",
    "href": "blog/index.html#section-8",
    "title": "Blog",
    "section": "2016",
    "text": "2016"
  },
  {
    "objectID": "blog/2024/05/11/optimal_threshold/index.html",
    "href": "blog/2024/05/11/optimal_threshold/index.html",
    "title": "最优分类阈值",
    "section": "",
    "text": "这里我们借助scikit-learn来探讨分类问题中阈值的选择。\n\n数据准备和参数选择\n首先是数据准备：\n\nimport matplotlib.pyplot as plt\nimport numpy as np\nimport pandas as pd\n\nfrom sklearn.datasets import load_breast_cancer\nfrom sklearn.model_selection import train_test_split\nfrom sklearn.metrics import confusion_matrix\n\nnp.set_printoptions(suppress=True, precision=8, linewidth=1000)\npd.options.mode.chained_assignment = None\npd.set_option('display.max_columns', None)\npd.set_option('display.width', None)\n\ndata = load_breast_cancer()\nX = data[\"data\"]\ny = data[\"target\"]\n\nXtrain, Xvalid, ytrain, yvalid = train_test_split(X, y, test_size=.20, random_state=516)\n\nprint(f\"Xtrain.shape: {Xtrain.shape}\")\nprint(f\"Xvalid.shape: {Xvalid.shape}\")\n\nXtrain.shape: (455, 30)\nXvalid.shape: (114, 30)\n\n\n模型我们这里选择随机森林。超参的选择，基于GridSearchCV，这里也不赘述。有一个点需要说明，由于使用的是肿瘤数据集，在这种情况下，我们更关注的是recall，即尽量减少假阴性的情况。因而，我们在训练模型时，也是将recall作为评价指标。\n\nfrom sklearn.ensemble import RandomForestClassifier\nfrom sklearn.model_selection import GridSearchCV\n\nparam_grid = {\n    \"n_estimators\": [100, 150, 250],\n    \"min_samples_leaf\": [2, 3, 4],\n    \"ccp_alpha\": [0, .1, .2, .3]\n    }\n\nmdl = GridSearchCV(\n    RandomForestClassifier(random_state=516), \n    param_grid, \n    scoring=\"recall\", \n    cv=5\n    )\n\nmdl.fit(Xtrain, ytrain)\n\nprint(f\"best parameters: {mdl.best_params_}\")\n\nbest parameters: {'ccp_alpha': 0, 'min_samples_leaf': 4, 'n_estimators': 100}\n\n\n\n\n模型预测\n拿到模型后，自然我们可以开始预测：\n\nypred = mdl.predict_proba(Xvalid)[:,1]\nypred\n\narray([0.005     , 0.82743637, 0.97088095, 0.        , 0.        , 1.        , 0.98020202, 0.67380556, 0.        , 0.99333333, 0.9975    , 0.30048576, 0.9528113 , 0.99666667, 0.04102381, 0.99444444, 1.        , 0.828226  , 0.        , 0.        , 0.97916667, 1.        , 0.99607143, 0.90425163, 0.        , 0.02844156, 0.99333333, 0.98183333, 0.9975    , 0.08869769, 0.97369841, 0.        , 1.        , 0.71100866, 0.96022727, 0.        , 0.71200885, 0.06103175, 0.005     , 0.99490476, 0.1644127 , 0.        , 0.23646934, 1.        , 0.57680164, 0.64901715, 0.9975    , 0.61790818, 0.95509668, 0.99383333, 0.04570455, 0.97575758, 1.        , 0.47115815, 0.92422619, 0.77371415, 0.        , 1.        , 0.26198657, 0.        , 0.28206638, 0.95216162, 0.98761905, 0.99464286, 0.98704762, 0.85579351, 0.10036905, 0.00222222, 0.98011905, 0.99857143, 0.92285967, 0.95180556, 0.97546947, 0.84433189, 0.005     , 0.99833333, 0.83616339, 1.        , 0.9955    , 1.        , 0.99833333, 1.        ,\n       0.86399315, 0.9807381 , 0.        , 0.99833333, 0.9975    , 0.        , 0.98733333, 0.96822727, 0.23980827, 0.7914127 , 0.        , 0.98133333, 1.        , 1.        , 0.89251019, 0.9498226 , 0.18943254, 0.83494391, 0.9975    , 1.        , 0.77079113, 0.99722222, 0.30208297, 1.        , 0.92111977, 0.99428571, 0.91936508, 0.47118074, 0.98467172, 0.006     , 0.05750305, 0.96954978])\n\n\n这个时候，我们要讲的东西就来了。一般地，我们会选择0.50作为分类阈值，即大于0.50的为正类，小于0.50的为负类。\n\nypred = mdl.predict_proba(Xvalid)[:,1].reshape(-1, 1)\nyhat = mdl.predict(Xvalid).reshape(-1, 1)\npreds = np.concatenate([ypred, yhat], axis=1)\nprint(preds)\nprint(confusion_matrix(yvalid, yhat))\n\n[[0.005      0.        ]\n [0.82743637 1.        ]\n [0.97088095 1.        ]\n [0.         0.        ]\n [0.         0.        ]\n [1.         1.        ]\n [0.98020202 1.        ]\n [0.67380556 1.        ]\n [0.         0.        ]\n [0.99333333 1.        ]\n [0.9975     1.        ]\n [0.30048576 0.        ]\n [0.9528113  1.        ]\n [0.99666667 1.        ]\n [0.04102381 0.        ]\n [0.99444444 1.        ]\n [1.         1.        ]\n [0.828226   1.        ]\n [0.         0.        ]\n [0.         0.        ]\n [0.97916667 1.        ]\n [1.         1.        ]\n [0.99607143 1.        ]\n [0.90425163 1.        ]\n [0.         0.        ]\n [0.02844156 0.        ]\n [0.99333333 1.        ]\n [0.98183333 1.        ]\n [0.9975     1.        ]\n [0.08869769 0.        ]\n [0.97369841 1.        ]\n [0.         0.        ]\n [1.         1.        ]\n [0.71100866 1.        ]\n [0.96022727 1.        ]\n [0.         0.        ]\n [0.71200885 1.        ]\n [0.06103175 0.        ]\n [0.005      0.        ]\n [0.99490476 1.        ]\n [0.1644127  0.        ]\n [0.         0.        ]\n [0.23646934 0.        ]\n [1.         1.        ]\n [0.57680164 1.        ]\n [0.64901715 1.        ]\n [0.9975     1.        ]\n [0.61790818 1.        ]\n [0.95509668 1.        ]\n [0.99383333 1.        ]\n [0.04570455 0.        ]\n [0.97575758 1.        ]\n [1.         1.        ]\n [0.47115815 0.        ]\n [0.92422619 1.        ]\n [0.77371415 1.        ]\n [0.         0.        ]\n [1.         1.        ]\n [0.26198657 0.        ]\n [0.         0.        ]\n [0.28206638 0.        ]\n [0.95216162 1.        ]\n [0.98761905 1.        ]\n [0.99464286 1.        ]\n [0.98704762 1.        ]\n [0.85579351 1.        ]\n [0.10036905 0.        ]\n [0.00222222 0.        ]\n [0.98011905 1.        ]\n [0.99857143 1.        ]\n [0.92285967 1.        ]\n [0.95180556 1.        ]\n [0.97546947 1.        ]\n [0.84433189 1.        ]\n [0.005      0.        ]\n [0.99833333 1.        ]\n [0.83616339 1.        ]\n [1.         1.        ]\n [0.9955     1.        ]\n [1.         1.        ]\n [0.99833333 1.        ]\n [1.         1.        ]\n [0.86399315 1.        ]\n [0.9807381  1.        ]\n [0.         0.        ]\n [0.99833333 1.        ]\n [0.9975     1.        ]\n [0.         0.        ]\n [0.98733333 1.        ]\n [0.96822727 1.        ]\n [0.23980827 0.        ]\n [0.7914127  1.        ]\n [0.         0.        ]\n [0.98133333 1.        ]\n [1.         1.        ]\n [1.         1.        ]\n [0.89251019 1.        ]\n [0.9498226  1.        ]\n [0.18943254 0.        ]\n [0.83494391 1.        ]\n [0.9975     1.        ]\n [1.         1.        ]\n [0.77079113 1.        ]\n [0.99722222 1.        ]\n [0.30208297 0.        ]\n [1.         1.        ]\n [0.92111977 1.        ]\n [0.99428571 1.        ]\n [0.91936508 1.        ]\n [0.47118074 0.        ]\n [0.98467172 1.        ]\n [0.006      0.        ]\n [0.05750305 0.        ]\n [0.96954978 1.        ]]\n[[35  3]\n [ 1 75]]\n\n\n但是，这个阈值是可以调整的。我们可以通过调整阈值来达到不同的目的。比如，我们可以通过调整阈值来减少假阴性的情况，这在类别不平衡时尤为重要。\n\n\n阈值的选择\n我们介绍几种常用的方法。\n\n1. 阳性类别prevalance\n我们看下这个数据集中阳性类别的比例：\n\nprint(f\"Proportion of positives in training set: {ytrain.sum() / ytrain.shape[0]:.2f}\")\n\nProportion of positives in training set: 0.62\n\n\n这个toy数据集很夸张哈，达到了0.62。在实际应用中，这个比例可能只有10%或者1%。这里我们只是拿它示例哈，用这个prevalance来作为阈值。\n\nthresh = 1- ytrain.sum() / ytrain.shape[0]\nyhat = np.where(ypred &lt;= thresh, 0, 1)\nprint(confusion_matrix(yvalid, yhat))\n\n[[34  4]\n [ 0 76]]\n\n\n考虑prevalance的方法，可以在类别不平衡的情况下，减少假阴性的情况。\n\n\n2. 最优F1指数\nF1指数是precision和recall的调和平均数。我们可以通过最大F1指数来选择最优的阈值。\n\n\nThreshold using optimal f1-score: 0.471.\n\n\nF1最高为0.471，我们采用它来进行预测：\n\nthresh = .471\nyhat = np.where(ypred &lt;= thresh, 0, 1)\nprint(confusion_matrix(yvalid, yhat))\n\n[[34  4]\n [ 0 76]]\n\n\n\n\n3. ROC曲线\n我们可以通过ROC曲线来选择最优的阈值。ROC曲线下的面积AUC越大，说明模型越好。我们可以选择ROC曲线最靠近左上角的点作为最优阈值。\n\n\n\n\n\n\n\n\n\n\n\n4. PRC曲线\nPRC曲线是precision-recall曲线。相比于ROC曲线，PRC曲线更适合类别不平衡的情况。我们主要选择PRC曲线最靠近右上角的点作为最优阈值。\n\n\n\n\n\n\n\n\n\nSelected threshold using precision-recall curve: 0.674.\n\n\n\n\n5. 分别关注precision和recall\n我们可以通过调整阈值来分别关注precision和recall。比如，我们可以通过调整阈值来提高recall，减少假阴性的情况。\n\n\n\n\n\n\n\n\n\n\n代码已经放进了星球里。\n\n\nDid you find this page helpful? Consider sharing it 🙌\n\n\n\n\n\n\n\n\nCitationBibTeX citation:@online{lu2024,\n  author = {Lu, Zhen},\n  title = {最优分类阈值},\n  date = {2024-05-11},\n  url = {https://leslie-lu.github.io//blog/2024/05/11/optimal_threshold},\n  langid = {en}\n}\nFor attribution, please cite this work as:\nLu, Zhen. 2024. “最优分类阈值.” May 11, 2024. https://leslie-lu.github.io//blog/2024/05/11/optimal_threshold."
  },
  {
    "objectID": "blog/2024/05/13/hierarchical_composite_endpoints/index.html",
    "href": "blog/2024/05/13/hierarchical_composite_endpoints/index.html",
    "title": "Hierarchical composite endpoints治疗效应的可视化",
    "section": "",
    "text": "复合终点\n有时，根据主要研究目的，我们很难从多个终点指标中选出其中某一个作为主要终点，此时，我们可以利用复合终点来作为主要终点。\nHierarchical composite endpoints (HCE)可以整合不同类型、不同重要性终点成一个有序终点指标，以表示患者经历的不同严重程度的终点。如，在固定随访的RCT中，outcomes of interest可以是death、hospitalization，而这两个终点存在严重程度的差异。很明显，死亡是最严重的。同样最终死亡的两个患者，生存时间更长，意味治疗效应更好；同样最终住院的两个患者，入院前时间更长，治疗效应更好；同样未住院的两个患者，某一实验室指标的change from baseline更大，效应更好。\n对于这种HCE，我们可以计算win odds(Gasparyan et al. 2021)来比较组间差异，然而，治疗效应的可视化受到复合终点的影响，不容易像单纯的生存曲线那样用合适的工具可视化出来。\n针对这一问题，AstraZeneca的Martin Karpefors等人提出了一种新的方法，即maraca plot(Karpefors, Lindholm, and Gasparyan 2023)。这种方法可以将复合终点中time to event(TTE)以及连续性终点的治疗效应可视化出来，同时也可以用来比较不同治疗组之间的差异。对应的R包可以方便地实现这一点。\n\n\nmaraca plot\nmaraca基于ggplot2，其中，对于TTE采用Kaplan-Meier曲线展示cumulative proportions，对于连续性终点可选用箱线图、violin plot以及scatter plot展示连续性分布。这种方法可以同时展示HCE的不同组成成分。\n来看一个例子。\n\nlibrary(maraca)\ndata(hce_scenario_a, package = \"maraca\")\ndata &lt;- hce_scenario_a\ndata |&gt; head()\n\n  SUBJID              GROUP GROUPN      AVAL0       AVAL    TRTP\n1      1          Outcome I      0 120.440921   120.4409  Active\n2      2 Continuous outcome  40000   3.345229 40003.3452 Control\n3      3 Continuous outcome  40000  22.802615 40022.8026  Active\n4      4          Outcome I      0 577.311386   577.3114 Control\n5      5         Outcome II  10000 781.758081 10781.7581  Active\n6      6        Outcome III  20000 985.097981 20985.0980 Control\n\n\n具体变量意义，大家可以查看?hce_scenario_a。\n可视化如下：\n\ncolumn_names &lt;- c(outcome = \"GROUP\", arm = \"TRTP\", value = \"AVAL0\")\ntte_outcomes &lt;- c(\"Outcome I\", \"Outcome II\", \"Outcome III\", \"Outcome IV\")\ncontinuous_outcome &lt;- \"Continuous outcome\"\narm_levels &lt;- c(active = \"Active\", control = \"Control\")\nmaraca_object &lt;- maraca(\n  data, tte_outcomes, continuous_outcome, arm_levels, column_names,\n  fixed_followup = 3*365, compute_win_odds = TRUE\n)\nAZ_colors &lt;- c(\"#830051\", \"#F0AB00\")\nplot(maraca_object, density_plot_type = \"default\") + theme_bw() +\n  scale_color_manual(values = AZ_colors) +\n  scale_fill_manual(values = AZ_colors)\n\n\n\n\n\n\n\n\n\n\n结果解释\n怎么看这张图？\n首先是x轴上HCE的5个组成成分，x轴上每个成分的长度大小，代表了患者达到不同成分终点的比例，可以看到，continuous outcome的比例最大，说明这个终点的患者所占比例最大。其次，cumulative percentage显示active组在四个TTE终点上是存在差异的。再然后是continuous outcome的分布，偏向x轴右侧代表change from baseline更大。而这些结合起来，就是win odds的结果，可以看到，和我们从可视化的角度看到的结果是一致的。\n代码已经放进了星球里。\n\n\n\n\n\n\n\n\n\n\nDid you find this page helpful? Consider sharing it 🙌\n\nGasparyan, S. B., E. K. Kowalewski, F. Folkvaljon, O. Bengtsson, J. Buenconsejo, J. Adler, and G. G. Koch. 2021. “Power and Sample Size Calculation for the Win Odds Test: Application to an Ordinal Endpoint in COVID-19 Trials.” Journal Article. Journal of Biopharmaceutical Statistics 31 (6): 765–87.\n\n\nKarpefors, M., D. Lindholm, and S. B. Gasparyan. 2023. “The Maraca Plot: A Novel Visualization of Hierarchical Composite Endpoints.” Journal Article. Clinical Trials (London, England) 20 (1): 84–88. https://doi.org/10.1177/17407745221134949.\n\nCitationBibTeX citation:@online{lu2024,\n  author = {Lu, Zhen},\n  title = {Hierarchical Composite {endpoints治疗效应的可视化}},\n  date = {2024-05-13},\n  url = {https://leslie-lu.github.io//blog/2024/05/13/hierarchical_composite_endpoints},\n  langid = {en}\n}\nFor attribution, please cite this work as:\nLu, Zhen. 2024. “Hierarchical Composite\nEndpoints治疗效应的可视化.” May 13, 2024. https://leslie-lu.github.io//blog/2024/05/13/hierarchical_composite_endpoints."
  },
  {
    "objectID": "cv/index.html",
    "href": "cv/index.html",
    "title": "Curriculum vitæ",
    "section": "",
    "text": "Download current CV"
  },
  {
    "objectID": "news/index.html",
    "href": "news/index.html",
    "title": "What I’m doing now",
    "section": "",
    "text": "May 11 2024: 🚀✨🎉 网站由 rmarkdown 更新为 quarto 支持。Hello World！"
  },
  {
    "objectID": "talks/index.html",
    "href": "talks/index.html",
    "title": "Talks",
    "section": "",
    "text": "This page contains the source code, links, and slides for various workshops, talks, lectures, and presentations I’ve given."
  },
  {
    "objectID": "talks/index.html#section",
    "href": "talks/index.html#section",
    "title": "Talks",
    "section": "2024",
    "text": "2024"
  }
]